| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/05/2026 | ±1.7% | +1.1% | over-priced |
| 05/06/2026 | ±2.2% | +0.3% | over-priced |
| 02/06/2026 | ±2.9% | +2.8% | over-priced |
| 08/06/2025 | ±2.4% | +0.1% | over-priced |
| 05/07/2025 | ±2.4% | +1.5% | over-priced |
| 02/07/2025 | ±2.5% | -0.6% | over-priced |
| 08/06/2024 | ±4.1% | +1.4% | over-priced |
| 05/07/2024 | ±1.6% | -0.3% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $3.01 | $4.4B | $595M |
| Q2 FY2026 | $2.72 | $4.3B | $544M |
| Q1 FY2026 | $2.79 | $4.2B | $563M |
| Q4 FY2025 | $2.95 | $4.2B | $604M |
Raymond James Financial, Inc. (RJF) reports in 75 days, with the next report estimated for 11/26/2026. Across the last 8 reports, options priced an average ±2.5% earnings move while the stock actually moved 1.0% on average — the market has systematically over-priced RJF's earnings risk. Fundamentals into the print: EPS up 42.0% year-over-year, revenue up 13.5%. QuantLogix's live 5-factor engine currently reads RJF as a neutral at 56/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →